Considerations for Randomized Controlled Trials During Future Filovirus Outbreaks Reply

被引：0
|
作者：
Ellenberg, Susan S. [1 ]
Keusch, Gerald T. [2 ,3 ,4 ,5 ]
Babiker, Abdel G. [6 ]
Edwards, Kathryn M. [7 ]
Lewis, Roger J. [8 ]
Lundgren, Jens D. [9 ]
Wells, Charles D. [10 ]
Wabwire-Mangen, Fred [11 ]
McAdam, Keith P. W. J. [12 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA
[3] Boston Univ, Sch Med, Dept Global Hlth, Boston, MA 02215 USA
[4] Boston Univ, Sch Publ Hlth, Dept Med, Boston, MA 02215 USA
[5] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA
[6] UCL, Med Res Council Clin Trials Unit, London, England
[7] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN USA
[8] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA
[9] Univ Copenhagen, Dept Infect Dis, Copenhagen, Denmark
[10] Sanofi US, Infect Dis Unit, Bridgewater, NJ USA
[11] Makerere Univ Sch Publ Hlth, Dept Epidemiol, Kampala, Uganda
[12] London Sch Hyg & Trop Med, Dept Clin & Trop Med, London, England
来源：
CLINICAL INFECTIOUS DISEASES | 2018年 / 67卷 / 06期
基金：
英国医学研究理事会;
关键词：
EBOLA;
D O I：
10.1093/cid/ciy250
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：985 / 986
页数：3
相关论文
共 50 条
  • [1] Considerations for Randomized Controlled Trials During Future Filovirus Outbreaks
    Jacob, Shevin T.
    Colebunders, Robert
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 984 - 985
  • [2] Protocol for testing filovirus treatments during outbreaks
    Nakkazi, Esther
    [J]. LANCET INFECTIOUS DISEASES, 2024, 24 (05): : e283 - e283
  • [3] THE LIMITS OF RANDOMIZED CONTROLLED TRIALS - REPLY
    CHALMERS, I
    [J]. BIRTH-ISSUES IN PERINATAL CARE, 1983, 10 (03): : 165 - 166
  • [4] REPORTING RANDOMIZED CONTROLLED TRIALS - REPLY
    MOHER, D
    RENNIE, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (17): : 1342 - 1343
  • [5] Registry randomized controlled trials: the future of surgical trials?
    Arafat, Yasser
    Wei, Matthew Y.
    Karanatsios, Bill
    Mendis, Shehara
    Gibbs, Peter
    Yeung, Justin M. C.
    [J]. ANZ JOURNAL OF SURGERY, 2023, 93 (09) : 2059 - 2060
  • [6] Randomized controlled trials in plastic surgery - Reply
    Veiga Filho, Joel
    Viega, Daniela F.
    Ferreira, Lydia M.
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (06) : 2081 - 2082
  • [7] Eligibility criteria of randomized controlled trials - Reply
    Fowler, Robert A.
    Van Spall, Harriette G. C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (01): : 39 - 40
  • [8] Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease
    Kraft, Colleen S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (10) : 1295 - 1296
  • [9] Pharmacogenetics in randomized controlled trials: considerations for trial design
    van der Baan, Frederieke H.
    Klungel, Olaf H.
    Egberts, Antoine C. G.
    Leufkens, Hubert G.
    Grobbee, Diederick E.
    Roes, Kit C. B.
    Knol, Mirjam J.
    [J]. PHARMACOGENOMICS, 2011, 12 (10) : 1485 - 1492
  • [10] ETHICAL CONSIDERATIONS IN RANDOMIZED CONTROLLED CLINICAL-TRIALS
    KODISH, E
    LANTOS, JD
    SIEGLER, M
    [J]. CANCER, 1990, 65 (10) : 2400 - 2404
12345